Figure 9

Schematic diagram of the anti-inflammatory effect of dioscin in inhibition of HSCs activation.

Dioscin decreased the level of intracellular MyD88 by down-regulating the expression of TLR4, leading to the attenuation of inflamma- tion, which in turn, blocked the activation of NF-κB, resulting in the inhibition of HSCs activation.